Growth Metrics

Sonoma Pharmaceuticals (SNOA) Share-based Compensation: 2010-2013

Historic Share-based Compensation for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Mar 2013 value amounting to $204,000.

  • Sonoma Pharmaceuticals' Share-based Compensation fell 55.65% to $204,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $1.2 million, marking a year-over-year decrease of 55.48%. This contributed to the annual value of $224,000 for FY2025, which is 56.59% down from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Share-based Compensation stood at $204,000 for Q1 2013, which was down 24.44% from $270,000 recorded in Q4 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Share-based Compensation registered a high of $1.0 million during Q4 2011, and its lowest value of $368 during Q3 2010.
  • In the last 3 years, Sonoma Pharmaceuticals' Share-based Compensation had a median value of $460,000 in 2012 and averaged $508,000.
  • As far as peak fluctuations go, Sonoma Pharmaceuticals' Share-based Compensation surged by 139,845.65% in 2011, and later plummeted by 73.32% in 2012.
  • Quarterly analysis of 4 years shows Sonoma Pharmaceuticals' Share-based Compensation stood at $332,000 in 2010, then skyrocketed by 204.82% to $1.0 million in 2011, then tumbled by 73.32% to $270,000 in 2012, then crashed by 55.65% to $204,000 in 2013.
  • Its Share-based Compensation was $204,000 in Q1 2013, compared to $270,000 in Q4 2012 and $372,000 in Q3 2012.